4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-064905
Director sold 5,000 shares at $18.00 ($90,000)
- Director acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mirza Mansoor Raza · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-18 | Exercise or conversion : show line 1 in the form | +5,000 | $5.43 | $27,150 | 5,000 | D |
| 2020-12-18 | Sale : show line 2 in the form | −5,000 | $18.00 | $90,000 | 0 | D |
| Open-market sales · 5,000 sh · avg $18.00 · $90,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-18 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −5,000 | $5.43 | 2029-06-05 | 5,000 | 0 | D |
Loading xslF345X03/doc4.xml…